Patents by Inventor Whitney Ellis

Whitney Ellis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Electric vehicle charging apparatus, system and methods
    Patent number: 11964578
    Abstract: An electric vehicle charging system includes an interleaved DC-DC control system configured to facilitate providing electric charge to an electric vehicle battery and includes a controller communicatively coupled to the interleaved DC-DC control system. The interleaved DC-DC control system includes an inrush current limiting circuit, three parallel boost converters that are each configured to operate in a discrete phase, and unidirectional current circuitry. The controller includes electronic control circuitry configured to control the interleaved DC-DC control system and vehicle communication circuitry configured to establish charging protocols between the interleaved DC-DC control system and the electric vehicle battery.
    Type: Grant
    Filed: August 29, 2022
    Date of Patent: April 23, 2024
    Assignee: SPARKCHARGE, INC.
    Inventors: Christopher R. Ellis, Richard Whitney
  • Alphavirus replicon particles as immunological adjuvants
    Patent number: 8263092
    Abstract: The immune response to an antigen of interest, either in purified form or expressed via an alphavirus replicon particle, can be enhanced by the simultaneous administration of an alphavirus replicon particle which expresses interleukin-12. This allows for the use of significantly smaller quantities of the antigen and this immunization strategy can also eliminate the need for boosting administration of the antigen or it can reduce the number of boosts required for an effective immune response to the antigen.
    Type: Grant
    Filed: September 12, 2007
    Date of Patent: September 11, 2012
    Assignee: AlphaVax, Inc.
    Inventors: Jonathan F. Smith, Bolyn Hubby, Peter Berglund, Laura Copp, Whitney Ellis
  • ALPHAVIRUS REPLICON PARTICLES AS IMMUNOLOGICAL ADJUVANTS
    Publication number: 20120213813
    Abstract: The immune response to an antigen of interest, either in purified form or expressed via an alphavirus replicon particle, can be enhanced by the simultaneous administration of an alphavirus replicon particle which expresses interleukin-12. This allows for the use of significantly smaller quantities of the antigen and this immunization strategy can also eliminate the need for boosting administration of the antigen or it can reduce the number of boosts required for an effective immune response to the antigen.
    Type: Application
    Filed: September 12, 2007
    Publication date: August 23, 2012
    Applicant: AlphaVax, Inc.
    Inventors: Jonathan F. Smith, Bolyn Hubby, Peter Berglund, Laura Copp, Whitney Ellis